FINWIRES · TerminalLIVE
FINWIRES

Gold Falls Again As Dollar Rises After U.S. and Iran Fail to Reach a Peace Deal

-- Gold prices look set to be down for a second day, falling again early Monday as the dollar rose after weekend talks between the United States and Iran failed to reach a peace deal, leaving the Strait of Hormuz blocked and continuing the largest-ever oil supply shock.

Gold for May delivery was last seen down $51.90 to US$4,736.00 per ounce.

Talks between the U.S. and Iran ended without an agreement to end the war that has blocked the Strait of Hormuz and cut off the 20% of global daily oil demand supplied by Persian Gulf nations. The U.S. plans to blockade Iran's ports following the collapse of the negotiations and block any ships transiting the Strait that have paid a toll to Iran, continuing to keep oil from the market.

Oil prices have climbed by nearly half since the Feb. 28 start to the war, pushing up inflation in the U.S. and elsewhere, ending hopes for lower U.S. interest rates. The U.S. last week reported its Consumer Price Index surged by 3.3% annualized in March, up from 2.4% a month earlier.

The dollar was higher early, with the ICE dollar index last seen up 0.25 points to 98.90. Treasury yields were little changed, with the yield on the U.S. two-year note last seen unchanged at 3.81%, while the 10-year note was paying 4.33%, down 1.0 points.

Related Articles

Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Quest Diagnostics

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month price target at $235. This is based on a forward P/E of 21.9x our 2026 EPS estimate, a premium to DGX's three-year forward average of 16.8x due to our view of strengthening sales and earnings growth, backed by higher health care utilization trends and some regulatory relief due to postponement of lab reimbursement cuts until at least 2027. We think lab testing providers remain a relatively well-positioned area within health care given lower policy risks, supportive testing demand, and attractive earnings growth potential. On a compounded annual basis from 2025-2028, we expect near 8% EPS growth, raising our 2026 EPS to $10.73 from $10.60 and 2027 EPS to $11.50 from $11.42. We also anticipate additional smaller M&A opportunities, along with healthy dividend increases (recent 7.5% boost; shares yield 1.7%) as cash flow generation remains supportive over the near term.

$DGX
Research

Research Alert: Pega: Q1 Results Miss, But Strength In Pega Cloud Offsets

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEGA reported total revenue of $430M, missing consensus by $37.2M and declining 10% Y/Y, while non-GAAP EPS of $0.46 missed by $0.23 and fell 39% Y/Y. However, Pega Cloud revenue surged 36% Y/Y to $205M, now representing 47.7% of total revenue and validating the cloud transition thesis. Pega Cloud annual contract value (ACV) acceleration remains the standout metric, growing 29% Y/Y to $906.7M and accelerating from 23% growth in Q1, demonstrating continued strong demand for the company's AI workflow automation platform. Total ACV grew 12% Y/Y to $1.62B, with backlog increasing 16% Y/Y to $2.01B providing revenue visibility. We believe the robust cash flow generation of $206.5M in free cash flow and a solid balance sheet with $474M in cash provides financial flexibility for continued AI investment. Despite near-term profitability pressure, we expect the sustained Pega Cloud momentum and strong ACV growth to support the business transformation.

$PEGA
Asia

Air New Zealand CFO to Resign

Air New Zealand (ASX:AIZ, NZE:AIR) said that Chief Financial Officer Richard Thomson has resigned, effective Aug. 28, according to a Wednesday filing with the New Zealand bourse.The airline has started the process of searching for a new CFO, the filing added.

$ASX:AIZ$NZE:AIR